Share

KMS Medisurgi Limited

126.5

Last Updated 25.08.2025

Issuer Rating

Performance

Modest

Risk

Negligible

Recommendation

Sell

Market Cap

₹ 4.51M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks

126.5

Key Takeaways

Risk factor

Moderate default risk

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

KMS Medisurgi Ltd. engages in the manufacture of medical and surgical equipment. It focuses on the marketing and distribution of medical devices, surgical disposables, hemostat, surgery equipment, radiology, oncology, diagnostic equipment, cardiology, critical care, urology, research, and other scientific equipment. The company was founded by Gaurang Prataprai Kanakia on March 25, 1999 and is headquartered...

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks